Cargando…

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients

BACKGROUND/AIMS: The treatment for chronic hepatitis C (CHC) is removal of the virus in order to prevent progression to liver cirrhosis and hepatocellular carcinoma (HCC). Few data have been presented regarding the clinical significance of changes in the alanine aminotransferase (ALT) level in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yun Jung, Jang, Byoung Kuk, Kim, Eun Soo, Park, Kyung Sik, Cho, Kwang Bum, Chung, Woo Jin, Hwang, Jae Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326992/ https://www.ncbi.nlm.nih.gov/pubmed/22511902 http://dx.doi.org/10.3350/kjhep.2012.18.1.41

Ejemplares similares

Alanine Aminotransferase Elevation during Peginterferon Alpha-2a or Alpha-2b plus Ribavirin Treatment
por: Nakamura, Masato, et al.
Publicado: (2013)

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
por: Kim, Kyung Hoon, et al.
Publicado: (2011)

Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin
por: Kim, Kyung-Ah
Publicado: (2011)

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
por: Jung, Young Kul, et al.
Publicado: (2013)

Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome
por: Lee, Seung-Hwa, et al.
Publicado: (2016)

The Author's Response: Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase
por: Lee, Junggyu, et al.
Publicado: (2016)

Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response
por: Tseng, Chih-Wei, et al.
Publicado: (2014)

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
por: Jeong, Seok Hoo, et al.
Publicado: (2012)

Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)

Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
por: Lee, Hye Won, et al.
Publicado: (2020)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques
por: Huang, Xing-Jiu, et al.
Publicado: (2006)

Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
por: Manfredi, Roberto, et al.
Publicado: (2010)

Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization
por: Huynh, Tung, et al.
Publicado: (2018)

Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia
por: Lee, Seung Mi, et al.
Publicado: (2020)

Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
por: Hwang, Yong, et al.
Publicado: (2015)

Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients
por: Kim, Sehwa, et al.
Publicado: (2021)

Association between Elevated Alanine Aminotransferase and Urosepsis in Children with Acute Pyelonephritis
por: Kim, Dongwan, et al.
Publicado: (2016)

A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
por: Sinn, Dong Hyun, et al.
Publicado: (2017)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Remdesivir: Elevated aspartate aminotransferase and alanine aminotransferase levels: case report
Publicado: (2022)

Upper Limits of Normal for Serum Alanine Aminotransferase Levels in Chinese Han Population
por: Zheng, Ming-Hua, et al.
Publicado: (2012)

Updated upper limit of normal for serum alanine aminotransferase value in Vietnamese population
por: Huong, Nguyen Thi Cam, et al.
Publicado: (2022)

Salivary and Serum Aspartate Aminotransferases and Alanine Aminotransferases in Insulin-Dependent Diabetes Mellitus and Normal Children: A Comparative Study
por: Vinod, K. S., et al.
Publicado: (2018)

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
por: Kim, Yu Jin, et al.
Publicado: (2011)

Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation
por: Kim, Hyun Jeong, et al.
Publicado: (2020)

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
por: Heo, Nae-Yun, et al.
Publicado: (2013)

Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients
por: Watanabe, Takao, et al.
Publicado: (2016)

Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study
por: Zhang, Junli, et al.
Publicado: (2018)

Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
por: Shin, Su Rin, et al.
Publicado: (2017)

Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy
por: Ha, Yun-Sok, et al.
Publicado: (2019)

Alanine aminotransferase controls seed dormancy in barley
por: Sato, Kazuhiro, et al.
Publicado: (2016)

Assessment of the Efficacy of Reducing Peginterferon Alfa-2a and Ribavirin Dose on Virologic Response in Koreans with Chronic Hepatitis C
por: Kwon, Jung Hyun, et al.
Publicado: (2009)

Clinical Features of Hepatitis C Virus Carriers With Persistently Normal Alanine Aminotransferase Levels
por: Uto, Hirofumi, et al.
Publicado: (2012)

Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review
por: Kolahdoozan, Shadi, et al.
Publicado: (2020)

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
por: Zhou, Jing, et al.
Publicado: (2021)

Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
por: Jung, Chang Ho, et al.
Publicado: (2016)

Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin
por: Par, Gabriella, et al.
Publicado: (2013)

Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males
por: Choi, Yong Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g48np25bqada1bhhrpfvguv1os